Can a new pill save insulin cells in LADA diabetes?

NCT ID NCT07460336

Not yet recruiting Disease control Sponsor: Second Xiangya Hospital of Central South University Source: ClinicalTrials.gov ↗

First seen Mar 12, 2026 · Last updated Apr 24, 2026 · Updated 8 times

Summary

This study looks at whether a drug called cofrogliptin can help preserve the cells that make insulin in adults with latent autoimmune diabetes (LADA). LADA is a slow-progressing form of diabetes where the immune system attacks these cells. About 84 adults will take either standard treatment (metformin, insulin, and vitamin D) or standard treatment plus cofrogliptin for one year. The main goal is to see if cofrogliptin helps maintain insulin production better than standard care alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATENT AUTOIMMUNE DIABETES IN ADULTS (LADA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Second Xiangya Hospital, Central South University

Changsha, Hunan, 410000, China

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LATENT AUTOIMMUNE DIABETES IN ADULTS (LADA)